Global Influenza Diagnostics Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 RIDT
1.2.3 RT-PCR
1.2.4 Cell Culture
1.2.5 Others
1.3 Market by Application
1.3.1 Global Influenza Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Influenza Diagnostics Market Perspective (2017-2028)
2.2 Influenza Diagnostics Growth Trends by Region
2.2.1 Influenza Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Influenza Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Influenza Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Influenza Diagnostics Market Dynamics
2.3.1 Influenza Diagnostics Industry Trends
2.3.2 Influenza Diagnostics Market Drivers
2.3.3 Influenza Diagnostics Market Challenges
2.3.4 Influenza Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza Diagnostics Players by Revenue
3.1.1 Global Top Influenza Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Influenza Diagnostics Revenue
3.4 Global Influenza Diagnostics Market Concentration Ratio
3.4.1 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Diagnostics Revenue in 2021
3.5 Influenza Diagnostics Key Players Head office and Area Served
3.6 Key Players Influenza Diagnostics Product Solution and Service
3.7 Date of Enter into Influenza Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Diagnostics Breakdown Data by Type
4.1 Global Influenza Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Influenza Diagnostics Forecasted Market Size by Type (2023-2028)
5 Influenza Diagnostics Breakdown Data by Application
5.1 Global Influenza Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Influenza Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Influenza Diagnostics Market Size (2017-2028)
6.2 North America Influenza Diagnostics Market Size by Country (2017-2022)
6.3 North America Influenza Diagnostics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Influenza Diagnostics Market Size (2017-2028)
7.2 Europe Influenza Diagnostics Market Size by Country (2017-2022)
7.3 Europe Influenza Diagnostics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Influenza Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Influenza Diagnostics Market Size by Country (2017-2022)
8.3 Asia-Pacific Influenza Diagnostics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Influenza Diagnostics Market Size (2017-2028)
9.2 Latin America Influenza Diagnostics Market Size by Country (2017-2022)
9.3 Latin America Influenza Diagnostics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Influenza Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Influenza Diagnostics Market Size by Country (2017-2022)
10.3 Middle East & Africa Influenza Diagnostics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Influenza Diagnostics Introduction
11.1.4 BD Revenue in Influenza Diagnostics Business (2017-2022)
11.1.5 BD Recent Development
11.2 Abbott (Include Alere)
11.2.1 Abbott (Include Alere) Company Detail
11.2.2 Abbott (Include Alere) Business Overview
11.2.3 Abbott (Include Alere) Influenza Diagnostics Introduction
11.2.4 Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2017-2022)
11.2.5 Abbott (Include Alere) Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Influenza Diagnostics Introduction
11.3.4 Roche Revenue in Influenza Diagnostics Business (2017-2022)
11.3.5 Roche Recent Development
11.4 SIEMENS
11.4.1 SIEMENS Company Detail
11.4.2 SIEMENS Business Overview
11.4.3 SIEMENS Influenza Diagnostics Introduction
11.4.4 SIEMENS Revenue in Influenza Diagnostics Business (2017-2022)
11.4.5 SIEMENS Recent Development
11.5 Analytik Jena
11.5.1 Analytik Jena Company Detail
11.5.2 Analytik Jena Business Overview
11.5.3 Analytik Jena Influenza Diagnostics Introduction
11.5.4 Analytik Jena Revenue in Influenza Diagnostics Business (2017-2022)
11.5.5 Analytik Jena Recent Development
11.6 Quidel
11.6.1 Quidel Company Detail
11.6.2 Quidel Business Overview
11.6.3 Quidel Influenza Diagnostics Introduction
11.6.4 Quidel Revenue in Influenza Diagnostics Business (2017-2022)
11.6.5 Quidel Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Detail
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Influenza Diagnostics Introduction
11.7.4 Thermo Fisher Revenue in Influenza Diagnostics Business (2017-2022)
11.7.5 Thermo Fisher Recent Development
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Detail
11.8.2 Meridian Bioscience Business Overview
11.8.3 Meridian Bioscience Influenza Diagnostics Introduction
11.8.4 Meridian Bioscience Revenue in Influenza Diagnostics Business (2017-2022)
11.8.5 Meridian Bioscience Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Detail
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Influenza Diagnostics Introduction
11.9.4 BioMerieux Revenue in Influenza Diagnostics Business (2017-2022)
11.9.5 BioMerieux Recent Development
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Detail
11.10.2 Sekisui Diagnostics Business Overview
11.10.3 Sekisui Diagnostics Influenza Diagnostics Introduction
11.10.4 Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2017-2022)
11.10.5 Sekisui Diagnostics Recent Development
11.11 Response Biomedical
11.11.1 Response Biomedical Company Detail
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Influenza Diagnostics Introduction
11.11.4 Response Biomedical Revenue in Influenza Diagnostics Business (2017-2022)
11.11.5 Response Biomedical Recent Development
11.12 SA Scientific
11.12.1 SA Scientific Company Detail
11.12.2 SA Scientific Business Overview
11.12.3 SA Scientific Influenza Diagnostics Introduction
11.12.4 SA Scientific Revenue in Influenza Diagnostics Business (2017-2022)
11.12.5 SA Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Influenza Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of RIDT
Table 3. Key Players of RT-PCR
Table 4. Key Players of Cell Culture
Table 5. Key Players of Others
Table 6. Global Influenza Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Influenza Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Influenza Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Influenza Diagnostics Market Share by Region (2017-2022)
Table 10. Global Influenza Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Influenza Diagnostics Market Share by Region (2023-2028)
Table 12. Influenza Diagnostics Market Trends
Table 13. Influenza Diagnostics Market Drivers
Table 14. Influenza Diagnostics Market Challenges
Table 15. Influenza Diagnostics Market Restraints
Table 16. Global Influenza Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Influenza Diagnostics Market Share by Players (2017-2022)
Table 18. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2021)
Table 19. Ranking of Global Top Influenza Diagnostics Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Influenza Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Influenza Diagnostics Product Solution and Service
Table 23. Date of Enter into Influenza Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Influenza Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Influenza Diagnostics Revenue Market Share by Type (2017-2022)
Table 27. Global Influenza Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Influenza Diagnostics Revenue Market Share by Type (2023-2028)
Table 29. Global Influenza Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Influenza Diagnostics Revenue Market Share by Application (2017-2022)
Table 31. Global Influenza Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Influenza Diagnostics Revenue Market Share by Application (2023-2028)
Table 33. North America Influenza Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Influenza Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Influenza Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Influenza Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Influenza Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Influenza Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Influenza Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Influenza Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Influenza Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Influenza Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 43. BD Company Detail
Table 44. BD Business Overview
Table 45. BD Influenza Diagnostics Product
Table 46. BD Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
Table 47. BD Recent Development
Table 48. Abbott (Include Alere) Company Detail
Table 49. Abbott (Include Alere) Business Overview
Table 50. Abbott (Include Alere) Influenza Diagnostics Product
Table 51. Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
Table 52. Abbott (Include Alere) Recent Development
Table 53. Roche Company Detail
Table 54. Roche Business Overview
Table 55. Roche Influenza Diagnostics Product
Table 56. Roche Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
Table 57. Roche Recent Development
Table 58. SIEMENS Company Detail
Table 59. SIEMENS Business Overview
Table 60. SIEMENS Influenza Diagnostics Product
Table 61. SIEMENS Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
Table 62. SIEMENS Recent Development
Table 63. Analytik Jena Company Detail
Table 64. Analytik Jena Business Overview
Table 65. Analytik Jena Influenza Diagnostics Product
Table 66. Analytik Jena Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
Table 67. Analytik Jena Recent Development
Table 68. Quidel Company Detail
Table 69. Quidel Business Overview
Table 70. Quidel Influenza Diagnostics Product
Table 71. Quidel Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
Table 72. Quidel Recent Development
Table 73. Thermo Fisher Company Detail
Table 74. Thermo Fisher Business Overview
Table 75. Thermo Fisher Influenza Diagnostics Product
Table 76. Thermo Fisher Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
Table 77. Thermo Fisher Recent Development
Table 78. Meridian Bioscience Company Detail
Table 79. Meridian Bioscience Business Overview
Table 80. Meridian Bioscience Influenza Diagnostics Product
Table 81. Meridian Bioscience Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
Table 82. Meridian Bioscience Recent Development
Table 83. BioMerieux Company Detail
Table 84. BioMerieux Business Overview
Table 85. BioMerieux Influenza Diagnostics Product
Table 86. BioMerieux Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
Table 87. BioMerieux Recent Development
Table 88. Sekisui Diagnostics Company Detail
Table 89. Sekisui Diagnostics Business Overview
Table 90. Sekisui Diagnostics Influenza Diagnostics Product
Table 91. Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
Table 92. Sekisui Diagnostics Recent Development
Table 93. Response Biomedical Company Detail
Table 94. Response Biomedical Business Overview
Table 95. Response Biomedical Influenza DiagnosticsProduct
Table 96. Response Biomedical Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
Table 97. Response Biomedical Recent Development
Table 98. SA Scientific Company Detail
Table 99. SA Scientific Business Overview
Table 100. SA Scientific Influenza DiagnosticsProduct
Table 101. SA Scientific Revenue in Influenza Diagnostics Business (2017-2022) & (US$ Million)
Table 102. SA Scientific Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Influenza Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. RIDT Features
Figure 3. RT-PCR Features
Figure 4. Cell Culture Features
Figure 5. Others Features
Figure 6. Global Influenza Diagnostics Market Share by Application in 2021 & 2028
Figure 7. Hospitals Case Studies
Figure 8. POCT Case Studies
Figure 9. Others Case Studies
Figure 10. Influenza Diagnostics Report Years Considered
Figure 11. Global Influenza Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Influenza Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Influenza Diagnostics Market Share by Region: 2021 VS 2028
Figure 14. Global Influenza Diagnostics Market Share by Players in 2021
Figure 15. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Influenza Diagnostics Revenue in 2021
Figure 17. North America Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Influenza Diagnostics Market Share by Country (2017-2028)
Figure 19. United States Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Influenza Diagnostics Market Share by Country (2017-2028)
Figure 23. Germany Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Influenza Diagnostics Market Share by Region (2017-2028)
Figure 31. China Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Influenza Diagnostics Market Share by Country (2017-2028)
Figure 39. Mexico Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Influenza Diagnostics Market Share by Country (2017-2028)
Figure 43. Turkey Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Influenza Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. BD Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
Figure 46. Abbott (Include Alere) Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
Figure 47. Roche Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
Figure 48. SIEMENS Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
Figure 49. Analytik Jena Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
Figure 50. Quidel Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
Figure 51. Thermo Fisher Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
Figure 52. Meridian Bioscience Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
Figure 53. BioMerieux Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
Figure 54. Sekisui Diagnostics Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
Figure 55. Response Biomedical Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
Figure 56. SA Scientific Revenue Growth Rate in Influenza Diagnostics Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed